Clinical Trials Directory

Trials / Unknown

UnknownNCT05094193

Trocar-site Infiltration Versus TAP-block

Trocar-site Infiltration With Ropivacaine Versus Tranversus Abdominis Plane Block Following Laparoscopic Cholecystectomy: a Double-blinded, Randomized-controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Tunis University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

For symptomatic gall bladder disorders (cholelithiasis and cholecystitis), laparoscopic cholecystectomy (LC) has been considered as the gold standard treatment. However, these minimally invasive technique is associated with acute moderate pain during the 24 hours postoperative, which is routinely managed using opioids. The transversus abdominis plane (TAP) block has been used as part of a multimodal analgesia strategy. Besides, Wang et al found that TAP block is more effective than a conventional pain control, but not significatively different from another local incisional pain control that is port site infiltration.So, the aim of this study, is to compare the analgesic efficacy and safety of trocar-site infiltration with ropivacaine with ultrasound-guided TAP block following laparoscopic cholecystectomy when used as part of multimodal analgesia.

Conditions

Interventions

TypeNameDescription
PROCEDURETrocar-site infiltration20 mL of ropivacaine 0.375% (6 mL in 10 mm trocar site and 4 mL in 6 mm trocar site)
PROCEDURETAP blockbilateral ultrasound-guided TAP block with 20 mL of ropivacaine 0.375% in each side
PROCEDURETrocar site infiltration placebo20 mL of normal saline
PROCEDURETAP block placebobilateral ultrasound-guided TAP block with 20 mL of normal saline in each side

Timeline

Start date
2021-10-01
Primary completion
2021-12-31
Completion
2022-01-31
First posted
2021-10-26
Last updated
2021-10-26

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT05094193. Inclusion in this directory is not an endorsement.